Scholars@Duke publication: Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.

Publication , Journal Article

Xu, H; Elster, E; Batty, D; Berning, J; Burkly, L; Kampen, R; Swanson, S; Tadaki, D; Harlan, D; Kirk, A

Published in: Transplant Proc

2001

Transplant Proc

0041-1345

2001

1-2

223 / 224

United States

APA

Chicago

ICMJE

MLA

NLM

Xu, H., Elster, E., Batty, D., Berning, J., Burkly, L., Kampen, R., … Kirk, A. (2001). Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. Transplant Proc, 33(1–2), 223–224. https://doi.org/10.1016/s0041-1345(00)01983-7

Xu, H., E. Elster, D. Batty, J. Berning, L. Burkly, R. Kampen, S. Swanson, D. Tadaki, D. Harlan, and A. Kirk. “Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.” Transplant Proc 33, no. 1–2 (2001): 223–24. https://doi.org/10.1016/s0041-1345(00)01983-7.

Xu H, Elster E, Batty D, Berning J, Burkly L, Kampen R, Swanson S, Tadaki D, Harlan D, Kirk A. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. Transplant Proc. 2001;33(1–2):223–224.